PDL BioPharma, Inc. (PDLI) Tops Q3 EPS by 1c, Sales Beat Expectations

Go back to PDL BioPharma, Inc. (PDLI) Tops Q3 EPS by 1c, Sales Beat Expectations
PDL BioPharma, Inc. (NASDAQ: PDLI) Delayed: 2.47 --0 (-0%)
Previous Close $2.47    52 Week High $4.06 
Open $0.14    52 Week Low $2.58 
Day High $2.47    P/E 1.44 
Day Low $2.47    EPS $1.71 
Volume 1,000